A Highly Sensitive LC-MS/MS Method to Determine Novel Bruton's Tyrosine Kinase Inhibitor Spebrutinib: Application to Metabolic Stability Evaluation

Royal Society Open Science - United Kingdom
doi 10.1098/rsos.190434
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Royal Society

Related search

Validated LC-MS/MS Assay for Quantification of the Newly Approved Tyrosine Kinase Inhibitor, Dacomitinib, and Application to Investigating Its Metabolic Stability

PLoS ONE
Multidisciplinary
2019English

A Highly Sensitive and Rugged LC-MS/MS Method Development and Validation for Determination of Elvitegravir in Rat Plasma: Application to Pharmacokinetic Study

Asian Journal of Chemistry
Chemistry
2017English

Simple, Sensitive and Rapid Determination of Linifanib (ABT-869), a Novel Tyrosine Kinase Inhibitor in Rat Plasma by UHPLC-MS/MS

Chemistry Central Journal
Chemistry
2014English

Validation of an LC-MS/MS Method to Determine Five Immunosuppressants With Deuterated Internal Standards Including MPA

BMC Clinical Pharmacology
2012English

Highly Sensitive Feature Detection for High Resolution LC/MS

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2008English

Highly Sensitive Quantification of Key Regulatory Oxysterols in Biological Samples by LC-ESI-MS/MS

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2008English

Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor

Prescriber
Pharmacology
2018English

A Novel and Sensitive LC/MS/MS Method for Quantitation of Pyochelin in Human Sputum Samples From Cystic Fibrosis Patients

Biomarkers and Applications
2019English

LC–MS/MS Assay for Acetazolamide, a Carbonic Anhydrase Inhibitor in Human Plasma and Its Clinical Application

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy